Precigen (PGEN)
(Delayed Data from NSDQ)
$3.12 USD
-0.07 (-2.19%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $3.10 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Precigen, Inc. has a market cap of $950.53M, which represents its share price of $3.19 multiplied by its outstanding shares number of 297.97M. As a small-cap company, PGEN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PGEN 3.12 -0.07(-2.19%)
Will PGEN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
Other News for PGEN
PGEN falls 2.19% on October 10, leaving the technical picture intact
PGEN forms NR7 on October 9
Is PGEN positioned for a breakdown? Fell Below 50 Day Moving Average shows up after sliding 2.72%
PGEN Crossed Above 50 Day Moving Average on October 7
PGEN Fell Below 50 Day Moving Average on October 6